Calmare Therapeutics Inc (CTTC):企業の財務・戦略的SWOT分析

◆英語タイトル:Calmare Therapeutics Inc (CTTC) - Financial and Strategic SWOT Analysis Review
◆商品コード:GDME26138FSA
◆発行会社(調査会社):GlobalData
◆発行日:2021年4月
◆ページ数:25
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:Medical Devices
◆販売価格オプション(消費税別)
Site License(同一事業所内共有可)USD600 ⇒換算¥88,800見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD900 ⇒換算¥133,200見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Calmare Therapeutics Inc (CTI) is a bio therapeutic company that offers pain mitigation and wound care technologies. The company provides non-pharmacological, non-addictive and non-invasive solution for chronic neuropathic pain and wound care affliction patients. It offers Calmare, a pain therapy device for the treatment of chemotherapy-induced peripheral neuropathy. CTI provides distribution, patent and technology transfer, selling and licensing services. The company operates through universities, large and small corporations, and federal and private research centers. It offers a broad portfolio of technologies in life, electronic, nano and physical sciences. The company caters to military hospitals and clinics. CTI is headquartered in Fairfield, Connecticut, the US.

This comprehensive SWOT profile of Calmare Therapeutics Inc provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of GlobalData’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, GlobalData’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Calmare Therapeutics Inc including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including*,

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note*: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include,

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

【レポートの目次】

Table of Contents

Section 1 – About the Company

Calmare Therapeutics Inc – Key Information
Calmare Therapeutics Inc – Overview
Calmare Therapeutics Inc – Key Employees
Calmare Therapeutics Inc – Key Employee Biographies
Calmare Therapeutics Inc – Key Operational Heads
Calmare Therapeutics Inc – Major Products and Services
Calmare Therapeutics Inc – History
Calmare Therapeutics Inc – Company Statement
Calmare Therapeutics Inc – Locations And Subsidiaries
Calmare Therapeutics Inc
Head Office
Other Locations & Subsidiaries

Section 2 – Company Analysis

Calmare Therapeutics Inc – Business Description
Calmare Therapeutics Inc – Corporate Strategy
Calmare Therapeutics Inc – SWOT Analysis
SWOT Analysis – Overview
Calmare Therapeutics Inc – Strengths
Calmare Therapeutics Inc – Weaknesses
Calmare Therapeutics Inc – Opportunities
Calmare Therapeutics Inc – Threats
Calmare Therapeutics Inc – Key Competitors

Section 3 – Company Financial Performance Charts

Calmare Therapeutics Inc – Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts

Section 4 – Appendix

Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

Note*: Some sections may be missing if data is unavailable for the company

List of Tables

Calmare Therapeutics Inc, Key Information
Calmare Therapeutics Inc, Key Ratios
Calmare Therapeutics Inc, Share Data
Calmare Therapeutics Inc, Major Products and Services
Calmare Therapeutics Inc, History
Calmare Therapeutics Inc, Key Employees
Calmare Therapeutics Inc, Key Employee Biographies
Calmare Therapeutics Inc, Key Operational Heads
Calmare Therapeutics Inc, Other Locations
Calmare Therapeutics Inc, Subsidiaries
Calmare Therapeutics Inc, Key Competitors
Calmare Therapeutics Inc, SWOT Analysis
Calmare Therapeutics Inc, Ratios based on current share price
Calmare Therapeutics Inc, Annual Ratios
Calmare Therapeutics Inc, Interim Ratios
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

★海外企業調査レポート[Calmare Therapeutics Inc (CTTC):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Nissan Motor Co., Ltd.:企業の戦略・SWOT・財務分析
    Nissan Motor Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Nissan Motor Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Nu-Med Plus Inc (NUMD):医療機器:M&Aディール及び事業提携情報
    Summary Nu-Med Plus Inc (Nu-Med Plus) is a medical device company. The company offers medical products that deliver therapeutic doses of nitric oxide gas to patients. It provides nitric oxide gas delivery system, portable nitric oxide delivery system and nitric oxide dilution system. Nu-Med Plus’ ni …
  • Beactica AB-製薬・医療分野:企業M&A・提携分析
    Summary Beactica AB (Beactica) is a drug discovery company that focuses on the development of novel therapeutics. The company offers wide range of services such as fragment-based lead generation, kinetic and mechanistic characterization of inhibitors, extended rate analysis and antibody interaction …
  • RentPath, LLC:企業の戦略・SWOT・財務分析
    RentPath, LLC - Strategy, SWOT and Corporate Finance Report Summary RentPath, LLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Symic Biomedical Inc-製薬・医療分野:企業M&A・提携分析
    Summary Symic Biomedical Inc (Symic Biomedical) is a biopharmaceutical company that develops library of compounds that target and protect the ECM (extracellular matrix) from illness or injury-related degradation. The company’s ECM specific compounds facilitate local application, which enhances its a …
  • Shanghai Electric Group Co Ltd:戦略・SWOT・企業財務分析
    Shanghai Electric Group Co Ltd - Strategy, SWOT and Corporate Finance Report Summary Shanghai Electric Group Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Eaton Corporation plc:戦略・SWOT・企業財務分析
    Eaton Corporation plc - Strategy, SWOT and Corporate Finance Report Summary Eaton Corporation plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Telkom SA SOC Limited:戦略・SWOT・企業財務分析
    Telkom SA SOC Limited - Strategy, SWOT and Corporate Finance Report Summary Telkom SA SOC Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Cre8tek Ltd (FGO):石油・ガス:M&Aディール及び事業提携情報
    Summary Cre8tek Ltd (Cre8tek), formerly Marion Energy Ltd, is an oil and gas exploration and production company. The company explores, acquires, develops, produces and markets oil and gas. It has core operations in Clear Creek field located in the Uinta Basin. Cre8tek also holds interest in the addi …
  • Toromont Industries Ltd:企業の戦略・SWOT・財務情報
    Toromont Industries Ltd - Strategy, SWOT and Corporate Finance Report Summary Toromont Industries Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Invacare Corporation (IVC)-医療機器分野:企業M&A・提携分析
    Summary Invacare Corporation (Invacare) is a medical equipment company which develops, manufactures and distributes healthcare products for non-acute care, such as the home healthcare and long term care markets. The major products include power wheelchairs, custom manual wheelchairs, personal mobili …
  • Whole Foods Market Inc:企業の戦略・SWOT・財務情報
    Whole Foods Market Inc - Strategy, SWOT and Corporate Finance Report Summary Whole Foods Market Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Prescient Therapeutics Ltd (PTX)-製薬・医療分野:企業M&A・提携分析
    Summary Prescient Therapeutics Ltd (Prescient Therapeutics), formerly Virax Holdings Ltd is a clinical stage oncology company that develops novel drugs for the treatment of solid and hematological cancers. The company’s lead drug candidate includes PTX-200, a potent small molecule inhibitor of the A …
  • Actinium Pharmaceuticals Inc (ATNM):企業の財務・戦略的SWOT分析
    Summary Actinium Pharmaceuticals Inc (ATNM), formerly Cactus Ventures Inc is a biopharmaceutical company that provides development of cancer immunotherapies. The company provides pipeline products such as Iomab-B that is used for hematopoietic stem cells transplantation. It provides Iomab-B through …
  • Power Assets Holdings Limited:企業の戦略・SWOT・財務分析
    Power Assets Holdings Limited - Strategy, SWOT and Corporate Finance Report Summary Power Assets Holdings Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • TH Heavy Engineering Bhd (THHEAVY):企業の財務・戦略的SWOT分析
    TH Heavy Engineering Bhd (THHEAVY) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • Birks Group Inc (BGI):企業の財務・戦略的SWOT分析
    Birks Group Inc (BGI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Acorn Energy, Inc. (ACFN):石油・ガス:M&Aディール及び事業提携情報
    Summary Acorn Energy Inc (Acorn) is an energy technology holding company which operates electricity delivery, emergency back-up power generation, and remote monitoring and control systems through its subsidiaries. The company develops and produces sonar systems for the defense, HLS, energy and comme …
  • Acome:企業の戦略・SWOT・財務情報
    Acome - Strategy, SWOT and Corporate Finance Report Summary Acome - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, provid …
  • Airbus SE.:企業の戦略・SWOT・財務分析
    Airbus SE. - Strategy, SWOT and Corporate Finance Report Summary Airbus SE. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆